NCT02591732View on ClinicalTrials.gov

A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

CompletedOBSERVATIONAL
Enrollment

52,178

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Anticoagulation
Trial Locations (1)

2900

Local Institution, Hellerup

Sponsors
All Listed Sponsors
collaborator

University Hospital, Gentofte, Copenhagen

OTHER

lead

Bristol-Myers Squibb

INDUSTRY

NCT02591732 - A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark | Biotech Hunter | Biotech Hunter